Immunology

The immune system's double agents

A new Tel Aviv University study examined for the first time the development of a glioblastoma cancerous tumor in animal models with a normal immune system, in order to best simulate the development of the tumor in humans. ...

Medications

Personalized treatments for blood and bone cancer

Personalization, something made especially for you, can make everything better, from the clothes you wear to the car you drive. Now, the type of medical treatment you receive can also be personalized.

Health

US stem cell clinics boomed while FDA paused crackdown

Hundreds of clinics pushing unproven stem cell procedures caught a big break from the U.S. government in 2017: They would have three years to show that their questionable treatments were safe and worked before regulators ...

Oncology & Cancer

Improving leukemia therapy with targeted treatment approaches

In chronic leukemias, blocking the overactive kinase JAK2 by a targeted therapy approach is only mitigating the patients' symptoms, but cannot truly change the course of the disease. A study by the University of Basel has ...

Medical research

A fountain of youth for ageing stem cells in bone marrow

As we age, our bones become thinner, we suffer fractures more often, and bone-diseases such as osteoporosis are more likely to occur. One responsible mechanism involves the impaired function of the bone-marrow stem cells, ...

Oncology & Cancer

Blood cancer cures and care: Addressing leukemia and lymphoma

Every four minutes, someone in the United States is diagnosed with a type of blood cancer, such as lymphoma or leukemia. According to the American Cancer Society's estimates, approximately 60,530 cases of leukemia and 90,000 ...

Other

Sanofi buys US biotech firm in acquisition spree

French pharmaceutical giant Sanofi announced on Wednesday its second acquisition of a US firm in as many months, buying transplant drug company Kadmon for $1.9 billion (1.6 billion euros).

page 1 from 40